A year ago, amid deep concern over COVID-19 and frantic work to develop vaccines, some of pharmas heaviest hitters saw the possibility of reputational enhancement.
Novartis AG chief executive (CEO) Vas Narasimhan dubbed it a "remarkable, perhaps once-in-a generation opportunity" back in April during the company's first quarter earnings call. Eli Lilly CEO David Ricks, meanwhile, closely echoed this sentiment, stating the sector had a once in a generation opportunity to reset its reputation.
Indeed, the world watched news of vaccine development with bated breath. In the public mind, pharma companies came to be associated with hard-working scientists seeking to cure the world.
Yet it seems like that moment may already be passing, and the opportunity for rehabilitation in the public mind could disappear unless pharma companies take stock.
Earlier this year I warned that the industry may have put all of its eggs into the Covid-19 basket. A dive into our latest analysis of how the pharmaceutical sector is viewed through the crucial lens of its Environmental, Social and Corporate Governance (ESG) actions bears this out, suggesting that the sector may already have missed the boat.
Our insights last year pointed to an improvement in stakeholder perceptions for the sector in 2020, as many warmed to pharma companies thanks to the halo effect of the vaccines. And while recent polling of a sample of the general public by RepTrak indicates that this trend has continued, our latest intelligence finds that this improvement has been short lived.
The headline figure from our deep dive into millions of alternative data, including media, regulator, investor, government, public and NGO sources from December 1, 2020, to February 28 this year shows average ESG perceptions of pharma have since nosedived.
Now, out of a possible range of -100% to +100%, the sectors average ESG rating is -20%, compared to +10% in the previous quarter.
Whats going on? Last June, The Economist compared COVID-19 vaccine development to the way mass production of penicillin during the Second World War revitalised the industrys reputation.
Positive headlines have since dwindled. Media attention had shifted from stories of firms collaborating for the benefit of humanity onto more complex territory. High profile issues like vaccine nationalism, anti-vaxxers and pharma companies falling foul of international politics amid the debate over possible side effects have come to the forefront.
The focus on vaccine manufacturers AstraZeneca and Pfizer, meanwhile, has led to increased scrutiny on the companies histories of alleged corruption and ethical breaches.
The pharmaceutical sector is of course, far bigger than its work onCOVID-19. With the initial shock if not the consequences of the pandemic having passed, we may expect this trend to continue. Scandals that may have not received attention last year will once again garner column inches and retweets even as the pandemic remains a global issue.
Dragging the industry down
What are the crucial ESG factors dragging the industry down?Business ethics is the single-most concerning issue for the industry right now, with a score of -13%. Major lawsuits against Roche and Biogen have opened a Pandoras box of bribery and corruption allegations, garnering major pick-up on social media in the process.
Biogen, which had to pay $22 million to resolve allegations that it illegally paid insurance co-payments for thousands of patients in order to collect Medicare revenue, languishes bottom of our list of 20 companies, with a -67% rating. This represents a drop of -80% compared to the previous quarter.
Roche, the best perceived pharma firm in the previous quarter with +64%, is now seventh with a rating of -3%, having had to pay out a $12.5 million for false claims through Humanas Medicare Advantage programme.
However, unless more scandal emerges, the firms longer-term progress on key ESG issues such as supply chain sustainability means it is well-placed to bounce back. Other firms would do well to take note.
A second issue afflicting the industrys ESG rating is affordability and pricing, with 12 firms scoring negatively on this issue.
While AstraZeneca offered to sell its COVID-19 vaccine at cost price until the pandemic is over, Moderna and Pfizers recent announcement that their versions are likely to contribute at least $15 billion and $18.4 billion respectively to sales this year will have gone down far better with shareholders than the wider public.
This, no doubt, has contributed to Pfizers fall 14 places to 19th position on our ESG rankings of 20 firms, with a score of -65% compared to +14% in the previous quarter. While AstraZenecas ESG score has also dropped, it has only moved down one position to 13th. There is a good chance that its cost price decision will be remembered positively in years to come.
Negative perceptions of affordability and pricing extend beyond issues relating to COVID-19, of course. Price hikes by AbbVie, Bristol Myers Squibb, GSK, Pfizer, Sanofi and Teva in late January have contributed towards the narrative shift to more negative territory.
Hot on the heels of this spike in negative news, meanwhile, came the refusal of nine companies - Amgen, AZ, Eli Lilly, Merck, Novartis and Novo Nordisk among them - to sell therapies at the price legally required by section 340B of the US Public Health Services Act.
Not all bad
It is easy to focus purely on the negatives amid pharmas broader shift in ESG ratings, but the traffic is not all one-way.
The sector has received the most positive ESG-related coverage when it comes to access to medicines, most likely due to the publication of the Access to Medicines Index. This annual report has shone a light on a range of successful initiatives and companies that have developed compelling access plans for low and middle income countries.
Praise for Takedas Access First approach, Patient Assistance Programs and consideration of end-to end' patient access to treatment have played a major key role in its ESG ascent from +11% the previous quarter to +56%, giving it top spot on our index.
Also moving up the ranks is Bayer, which came in second place with +40%, an increase from +8% the previous quarter. The firms ascent is linked with drug safety, an area that also garnered overall positive ESG perceptions with Bayer playing an important role in a new alliance with CureVac, for the development of CVnCoV, a COVID vaccine.
A new challenge
The vast challenges of 2020 offered pharmaceutical companies the chance to re-forge their images in the court of public perception.
For instance, Pfizer paid for National Geographic to follow the development of a vaccine, while Johnson & Johnson launched a social media serieson the hunt for a vaccine, drawing a vast, global audience.
Our ESG findings, however, indicate that pharmaceutical firms that expected a long-termimage-polish borne from vaccine development were sorely misguided.Perceptions of an industry coming together to help the common cause have faded as the reality and complexities of the vaccine rollout kick in.
The narrative is likely to shift towards the global disparities in vaccine acquisition, and attention is shifting once again to the norms of pharma coverage that preceded COVID-19.
Despite all this, the opportunity described by the likes of Vas Narasimhan has not completely vanished. Utilising the opportunity, however, requires far more than some well thought out content and a few savvy marketing gestures.
It demands that firms fully react to growing ESG expectations, building ESG practice into their wider models whether or not they are helping vaccinate the world from COVID-19.It is only by making these changes, and taking the public along with them as they do so, that any fundamental, long lasting shift in perception is achievable.
Siera Torontow is the Managing Director of Healthcare and Consumer Practice at alva
Has pharma missed the boat? - PharmaTimes
- Validation and clinical applicability of a deep learning system for retinal disease (Tuesday, 10th August 2021) City, University of London - City,... - June 16th, 2021
- Physical works out the dark side of the mind in an honest way - Metro US - June 16th, 2021
- The Number One Voice Certain To Drive Your Leadership Off The Deep End - Forbes - June 16th, 2021
- Consumer Companies Bail on Non-Core Assets: "Deep is the New Wide" - Mergers & Acquisitions - June 16th, 2021
- Bengio Team Proposes Flow Network-Based Generative Models That Learn a Stochastic Policy From a Sequence of Actions - Synced - June 16th, 2021
- It's more than just skin-deep: Feel and look amazing with Bubble Skincare | Sponsored - Harvard Crimson - June 16th, 2021
- AI in Healthcare Market Drivers, Challenges, Opportunities and Competitive Strategy Over 2021-2031 | Nuance Communications, Inc., DeepMind... - June 16th, 2021
- NVIDIA and the battle for the future of AI chips - Wired.co.uk - June 16th, 2021
- Accelerating Deep Learning on the JVM with Apache Spark and NVIDIA GPUs - InfoQ.com - June 16th, 2021
- AI in Europe: Who's leading the way and where is it heading? - Siliconrepublic.com - June 16th, 2021
- Review: Bo Burnhams Inside is a successful depiction of a lonely mind - Los Angeles Times - June 16th, 2021
- Alma Allens biomorphic sculptures have minds of their own - Wallpaper* - June 16th, 2021
- AI In Healthcare Market Rapid Growth USD 120 Bn by 2028| IBM Corporation, NVIDIA Corporation, Nuance Communications, Microsoft, Intel Corporation,... - June 16th, 2021
- Microsoft & OneFlow Leverage the Efficient Coding Principle to Design Unsupervised DNN Structure-Learning That Outperforms Human-Designed... - June 4th, 2021
- Machine Learning Artificial intelligence Market Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2027 | AIBrain, Amazon, Anki,... - June 4th, 2021
- Mind the gap: why training is vital to pursuing transgender inclusion - TrainingZone.co.uk - June 4th, 2021
- Phaidra raises more cash from Mark Cuban and others to build the future of industrial automation - GeekWire - May 24th, 2021
- DeepMind reportedly lost a yearslong bid to win more independence from Google - The Verge - May 24th, 2021
- Aging With Honor and Dignity: An Intuitive Approach for Men - The Good Men Project - May 24th, 2021
- Damien Harris clearly wouldn't mind a trade that lands Julio Jones with Patriots - Patriots Wire - May 24th, 2021
- AI in Healthcare Market Rugged Expansion Foreseen by 2031 | Nuance Communications, Inc., DeepMind Technologies Limited, IBM Corporation The Courier -... - May 24th, 2021
- AI in Healthcare Market in deep Research about Growth & Competitive Analysis by 2021-2031 | Nuance Communications, Inc., DeepMind Technologies... - May 24th, 2021
- Dallas Comedy House Will Reopen With a New Name and Look - Eater Dallas - May 24th, 2021
- 3 Major Benefits of a Long-Term Insurance Carrier Relationship - Senior Housing News - May 24th, 2021
- IoT Cloud Company Tuya Smart Holds Meeting on Fast-tracked Connectivity and Innovation Amid COVID-19 Pandemic - Synced - May 24th, 2021
- DeepMind extends hunt for the worlds best A.I. researchers to Toronto - CNBC - May 10th, 2021
- ECO V2 by Pangeanic: Deep Adaptive Machine Translation Document Translator and Anonymization Solution - PRNewswire - May 10th, 2021
- Matters of the Mind: Compassion fatigue, vicarious trauma and hopelessness - The Indian Express - May 10th, 2021
- Prison education alums work with undergrads on theater piece | Cornell Chronicle - Cornell Chronicle - May 10th, 2021
- AI in Healthcare Market Insights, Deep Analysis of Key Vendor in the Industry 2021-2030 | Nuance Communications, Inc., DeepMind Technologies Limited,... - May 2nd, 2021
- Matisse & Sadko unveil the mind bending progressive tune 'Heal Me' - We Rave You - May 2nd, 2021
- The Deep-Sea Podcast review: The mind-boggling mysteries of the deep - New Scientist - May 1st, 2021
- Three Books: Zena Hitz *05 on a Life of the Mind - Princeton Alumni Weekly - May 1st, 2021
- Flavor 1st has Georgia on its mind | Produce News - TheProduceNews.com - May 1st, 2021
- Young attorney digs deep to make a genuine mark in the profession - Loop News Jamaica - May 1st, 2021
- Figures of Speech: 40 Ways to Improve your Writing - Visual Capitalist - May 1st, 2021
- Tony Bailie's Take on Nature: Bear in mind the simple principles of Leave No Trace - The Irish News - May 1st, 2021
- Food & Wine names 10 best pizza states in America and New York isnt in the top spot - KXAN.com - May 1st, 2021
- Essence Group Announces 'Peace of Mind' Strategy as Top Objective of All Future IoT Products and Services - PRNewswire - April 28th, 2021
- Centring of The Mind - Economic Times - April 28th, 2021
- PLU professors and students dive deep into the psychology of the pandemic - Pacific Lutheran University - April 28th, 2021
- Derby Undercard: Eclipse Winner Whitmore is a fan favorite in deep field of 13 for the Churchill Downs - Past The Wire - April 28th, 2021
- How Luxury Travel Is Leading the Recovery: A Skift Deep Dive - Skift - April 28th, 2021
- 'I recall it with deep despair': North Sea marks five years since Norway helicopter crash - News for the Oil and Gas Sector - Energy Voice - April 28th, 2021
- Single-Use Plastics Found at the Deepest Points of the Ocean - Technology Networks - April 28th, 2021
- Global Ai In Healthcare Market Top 10 Key players in 2021 |DeepMind Technologies Limited, IBM Corporation, Nuance Communications Inc, Microsoft,... - April 28th, 2021
- BlanQuil weighted blankets: Products and brand review - Medical News Today - April 28th, 2021
- A New Book Explores the Connections Between Music, Physics, and Neuroscience - Columbia University - April 28th, 2021
- Global Mindfulness Meditation Apps Market (2020) to Witness Huge Growth by 2026 | Deep Relax, Smiling Mind, Inner Explorer, Inc., Committee for... - April 19th, 2021
- Line of Duty, season 6 episode 5 recap: Davidson is in deep but who fired those cliffhanger shots? - The Telegraph - April 19th, 2021
- Calvin University Selects Noah Toly As Provost - News - Calvin News - April 19th, 2021
- I'm an insomniac who's tried everything from meds to sleep sprays. This meditation app is the only thing that' - Business Insider India - April 19th, 2021
- 'We've had this in mind for some time' - Gosden aims for another Blue Riband win - Racing Post - April 19th, 2021
- What two pieces of unrelated pop culture are forever connected in your mind? - The A.V. Club - April 19th, 2021
- Bringing China-US ties where they need to be - Chinadaily.com.cn - China Daily - April 8th, 2021
- Deep in the heart of the Texas Butterfly Ranch - The Picayune - April 8th, 2021
- Cultivating a Diverse and Inclusive Culture: Recruiting - ATD - ATD - ATD - April 8th, 2021
- The Mavericks Who Brought AI to the World - Review of Genius Makers by Cade Metz - Forbes - April 8th, 2021
- 'I can't unsee them': Rockland woman copes with trauma from Haiti earthquake by writing - Enterprise News - April 8th, 2021
- Q&A: How The Atlantic's Ed Yong navigated a year of deep coronavirus coverage - Poynter - April 8th, 2021
- Healthcare AI Market 2021 Is Rapidly Increasing Worldwide in Near Future | Top Companies Analysis- Apple, GE Healthcare, Google Deepmind Health, IBM... - April 8th, 2021
- Easter is when we go deep into the enduring stories of death and life - The National - April 4th, 2021
- How Open Source is Driving the Future of Data Science - RTInsights - April 4th, 2021
- Space Regime in Deep Distress: Experts The Diplomat - The Diplomat - April 4th, 2021
- Gulf News webinar to focus on fasting with health conditions during Ramadan | Uae - Gulf News - April 4th, 2021
- When it rains, it floods, and you better know what to do - Columbia Daily Herald - April 4th, 2021
- Opera Meets Film: How Opera is Used to Immerse Us Deeper into Anthony's Mind in 'The Father' - OperaWire - April 2nd, 2021
- Dive Deep Into These Mind-Blowing Underwater Photographer of the Year Entries - Yahoo News - April 2nd, 2021
- Sunfield Farm and Waldorf School dig deep to the root of learning - Port Townsend Leader - April 2nd, 2021
- Dear Eonni: A Filipino UAENA respects Lilac singer IU as a lyricist because her songs are 'active and awake' - PINKVILLA - April 2nd, 2021
- AI in Healthcare Market Is Set to Experience Revolutionary Growth by 2030 | Nuance Communications, Inc., DeepMind Technologies Limited KSU | The... - April 2nd, 2021
- Brain Tracking: Unraveling Mysteries of the Human Mind - WGEM - April 2nd, 2021
- On My Mind: The Solution To Gun Violence? More Guns, Apparently - WFAE - April 2nd, 2021
- System on Chips And The Modern Day Motherboards - Analytics India Magazine - April 2nd, 2021
- Artificial Intelligence Drug R&D: Market By New Business Developments, Innovations, And Top Companies Forecast To 2025 | Gatehouse Bio, Google... - April 2nd, 2021
- Artificial intelligence kept expanding through a turbulent year, with some exceptions - ZDNet - March 21st, 2021
- The Book Corner: The Deep by Rivers Solomon, Daveed Diggs, William Hutson, and Jonathan Snipes - University Press - March 21st, 2021
- 12-foot-deep sinkhole 'accidentally' discovered near Williams Arts Center The Lafayette - The Lafayette - March 21st, 2021
- DeepMind is building a team of A.I. researchers in New York - CNBC - March 16th, 2021
- AI & Robotics in the Global Defense Industry to Reach $61 Billion by 2027 - Robotics Anticipated to Account for the Largest Share of Expenditure -... - March 16th, 2021